March 10 (Reuters) - Mylan NV MYL.O :
* MYLAN PHARMACEUTICALS ULC LAUNCHES WIXELA® INHUB® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP), THE FIRST AVAILABLE BIOEQUIVALENT ALTERNATIVE TO ADVAIR® DISKUS® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER) IN CANADA